RetaMaps

Invision Health

Invision Health · 400 International Drive · Buffalo, NY 14221

2.4· 217 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Invision Health is a multi-specialty medical group in Buffalo, New York. Its website describes specialists in neurosurgery, neurology, internal medicine and physical therapy, plus medical massage, specialty spa treatments and an in-house medical supply store, and traces the practice's origins to the mid-1990s; physicians listed include Brian M. Karaszewski, MD, and Joseph DiPirro, MD. Its listing also includes weight-loss and hormone care. On Google it holds a 2.4-star rating across 217 reviews dating back to 2021, with 35 in the past year; reviewers most often mention the staff, and 23 mention scheduling.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 2.4
Google rating · 217 reviews
35
reviews in the past year (avg ★ 2.9)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-26. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★2.4 across 217 Google reviews. Of the 100 reviews we analyzed, 34 (34%) are positive (4–5★) and 63 (63%) are negative (1–2★).

What patients like

  • Friendly, helpful staff8 reviews
  • Feeling listened to5 reviews
  • Knowledgeable, professional providers4 reviews
  • Fair pricing and billing2 reviews

Common complaints

  • Scheduling or communication problems24 of 63 negative
  • Staff or front-desk issues23 of 63 negative
  • Billing, pricing or insurance problems9 of 63 negative
5★
29
4★
5
3★
3
2★
5
1★
58

Most recent Google reviews

Jjs P.★★★★★2026-09-13

Money hungry office.

Mason B.★★★★★2026-09-08

We need an option for ZERO stars, this place is run worse than any other business I've ever been to, absolutely the most egregious wait times in person and on the phone, just to get hung up on or rescheduled.

Edward O.★★★★★2026-08-26

There is reason this place has only 2.4 in reviews, it's bad . I went to two appointments with PA Christian Burgio. I paid out of pocket and didn't use insurance, both time the pa tested me too see if I was faking. Mind you the only ones to ever do that was the lying doctors that the insurance company hired in my workers comp case to say the opposite of what my doctors were saying. I have seen 8 different doctors for my injuries. I have 6 MRI s. I asked him a simple question, why can't I walk , stand or sit for extended periods of time. He responded he didn't know, so I asked him if I could record the session, he said no it's against policy. Then I pointed out to him the answer was literally on one of the charts hanging in the room. He was rude and un caring . This was the worst pa i have ever seen. My advice is go somewhere else.

Kristi-Anne S.★★★★★2026-08-07

I just love Dr. Carlino and you will too. A gentleman and a scholar.

fran h.★★★★★2026-07-29

Been with Dr waghamare since 2008 he has been a caring and knowledgeable doctor when it came to my spine and all it's problems

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Buffalo

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs